Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

PHASE4UnknownINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Kidney; Complications, Allograft
Interventions
DRUG

Everolimus

Decrease the level of Tacrolimus and add on Everolimus instead of Mycophenolic acid which is standard treatment.

DRUG

Tacrolimus

Decrease the level of Tacrolimus and add on Everolimus instead of Mycophenolic acid which is standard treatment.

DRUG

Mycophenolic acid

Decrease the level of Tacrolimus and add on Everolimus instead of Mycophenolic acid which is standard treatment.

Trial Locations (1)

Unknown

RECRUITING

division of nephrology;Seoul St Mary's Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Seoul St. Mary's Hospital

OTHER